LADEL, CHRISTOPH HUBERTUS,BERTON, ALIX ANNE SIMONE,VALSESIA, ARMAND,FARMER, PIERRE JACQUES
申请号：
CA2881024
公开号：
CA2881024A1
申请日:
2013.08.05
申请国别(地区):
CA
年份:
2014
代理人:
摘要：
This application is directed to the use of biomarkers for predicting the sensitivity to treatment with an FGF-18 compound in a patient having a cartilage disorder, such as osteoarthritis, cartilage injury, fractures affecting joint cartilage or surgical procedures with impact on joint cartilage (e.g. Microfracture), in order to reduce the risk of adverse events and increase the overall benefit after therapy.
